A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. [electronic resource]
Producer: 19920304Description: 55-63; discussion 63-4 p. digitalISSN:- 0004-0010
- Acyclovir -- therapeutic use
- Adult
- Antibodies, Viral -- analysis
- Antigens, Differentiation, T-Lymphocyte -- analysis
- CD3 Complex
- Child
- Child, Preschool
- Cytomegalovirus -- immunology
- Drug Costs
- Female
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Liver Transplantation -- mortality
- Male
- Middle Aged
- Muromonab-CD3 -- adverse effects
- Opportunistic Infections -- immunology
- Prospective Studies
- Receptors, Antigen, T-Cell -- analysis
- T-Lymphocyte Subsets
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.